CBDL.US Cbd Life Sciences Inc

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Nov 13, 2026
0.0001 0.0005
Market cap
USD 611K
P/E
-
P/B
10.06x
ROE
-7.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CBDL.US undervalued?

Graham number

The Graham number of Cbd Life Sciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cbd Life Sciences Inc fundamental analysis

No fundamental analysis for Cbd Life Sciences Inc yet.

Cbd Life Sciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cbd Life Sciences Inc

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include such as hemp drops, recovery pain relief products, anxiety and sleep solutions, supplements, edibles, bath products, kosher products, and a full line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 20…

Full company profile